Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 80 years of age
- People who have been diagnosed with colorectal adenocarcinoma (a specific type of bowel cancer), confirmed by laboratory testing of tissue, according to the WHO 2022 classification
- People who have previously received treatments such as chemotherapy, radiation, targeted therapy, or immunotherapy, or who have not received any prior treatment — there is no restriction on this
- People who are able to understand what the study involves and are willing to sign a consent form (this can also be done by a legally authorised representative)
- People who are able to communicate clearly with the research team and are willing to follow all study procedures, including care and check-ups after surgery
Who may not be able to join:
- People with serious heart problems that significantly limit physical activity or cause symptoms at rest (confirm with trial site for exact classification)
- People with severe liver disease, based on a specific liver scoring system (confirm with trial site)
- People with severely reduced kidney function, or those already on dialysis due to kidney failure
- People with serious lung problems, such as very low oxygen levels while resting normally, or those who need long-term oxygen support or a breathing machine
- People who are currently taking part in another clinical trial, or who have done so in the four weeks before joining this study
- People who need emergency surgery due to a blocked, ruptured, or otherwise acutely affected bowel
- People with severe mental health conditions that could make it difficult to follow the study's care plan or attend follow-up appointments
- Women who are pregnant or breastfeeding
- People with any other health or test result that the investigating doctor considers would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Congqing Jiang, professor, Shanghai Zhongshan Hospital
Phone: +86 18771708286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of postoperative ileus ( POI) after surgery.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.